Yuxi Watson Biotechnology | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,449 results for “Yuxi Watson Biotechnology”

Trials

View all 192 →

BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

443 participants · First posted Apr 18, 2023

Evaluation of Staple Watson Wrist Arthrodesis

41 participants · First posted Jan 22, 2020

Psychoeducation in Preventing Postpartum Depression According to Watson

90 participants · First posted Jun 8, 2023

Drugs

View all 805 →

Immunoglobulin F(ab')2 fragment (Yuxi Jiuzhou Biotechnology)

Pneumococcal 13-Valent Conjugate Vaccine (Yuxi Walvax Biotechnology)

Meningococcal vaccine groups ACYW-135 conjugate (Yuxi Walvax Biotechnology)

Organizations

View all 272 →

Yuxi Walvax Biotechnology Co., Ltd.

China

WATSON LABORATORIES, INC.

United States

Watson Clinic Foundation, Inc

United States

News

View all 4180 →

China Approves Walvax's Third mRNA COVID-19 Vaccine Targeting Omicron JN.1

Teva and IBM Watson Partner to Accelerate AI-Driven Drug Repurposing Initiative

Zephyr AI Names Watson Pharmaceuticals Founder Dr. Allen Chao as CEO, Acquires Aster Insights to Accelerate Cancer Drug Development

Page 1 of 545